<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01832441</url>
  </required_header>
  <id_info>
    <org_study_id>00108</org_study_id>
    <nct_id>NCT01832441</nct_id>
  </id_info>
  <brief_title>Study Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Diabetes Mellitus.</brief_title>
  <acronym>BMACD</acronym>
  <official_title>Study Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Diabetes Mellitus. It is Self Funded (Patients' Own Funding) Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chaitanya Hospital, Pune</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chaitanya Hospital, Pune</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is Single arm, Single Centre trial to check the Safety and Efficacy of Bone Marrow
      Derived Autologous mono nuclear cells (100 Million per dose).trial to be conducted for 36
      months in patients with diabetes Mellitus in India,Primary outcome measure are abolition or
      reduction of insulin by&gt;50 percentage by the end of 6 months of ABMSCT-Any reduction in
      requirement of Insulin dosage and Improvement in HbA1C Level.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      his study is Single arm, Single Centre trial to check the Safety and Efficacy of Bone Marrow
      Derived Autologous mono nuclear cells (100 Million per dose).trial to be conducted for 36
      months in patients with diabetes Mellitus in India,Primary outcome measure are abolition or
      reduction of insulin by&gt;50 percentage by the end of 6 months of ABMSCT-Any reduction in
      requirement of Insulin dosage and Improvement in HbA1C Level.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2014</start_date>
  <completion_date type="Anticipated">September 2016</completion_date>
  <primary_completion_date type="Anticipated">September 2016</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Abolition or reduction of insulin by &gt;50 percentage</measure>
    <time_frame>6 months</time_frame>
    <description>- Abolition or reduction of insulin by &gt;50 percentage of ABMSCT by 6 month</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improvement in HbA1C levels</measure>
    <time_frame>6 months</time_frame>
    <description>Improvement in HbA1C levels as compared to baseline by the end of 6 months .</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Diabetes Mellitus.</condition>
  <arm_group>
    <arm_group_label>Transfer of autologous MNC intrathecally</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>single arm Intra thecal transplantation of autologous MNC</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Intra thecal transplantation of autologous MNC</intervention_name>
    <description>Intra thecal inj.of 100 millions MNC in 3 doses at 7 days interval</description>
    <arm_group_label>Transfer of autologous MNC intrathecally</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient should suffer from Diabetes Mellitus.

          -  Willingness to undergo Bone Marrow derived Autologous cell Therapy.

          -  Ability to comprehend the explained protocol and thereafter give an informed consent
             as well as sign the required Informed Consent form(ICF) for the study.

          -  Ability and willingness to regular visit to hospital for protocol procedures and
             follow up

        Exclusion Criteria:

          -  Patient with History of Immunodeficiency HIV+,Hepatitis B ,HBV and History of Life
             threatening allergic or immune -Mediated Reaction. the site of bone marrow aspiration
             potentially limiting Procedure. Alcohol and drug abuse / dependence. Patients with
             History of Hypertension and Hypersensitive.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ANANT E BAGUL, M.S</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHAITANYA HOSPITAL</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sachin P Jamadar, D Ortho</last_name>
    <phone>+918888788880</phone>
    <email>sac2751982@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Smita S Bhoyar, B.A.M.S.PGCR</last_name>
    <phone>9372620569</phone>
    <email>drsmitabhoyar@rediff.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Chaitanya Hospital</name>
      <address>
        <city>Pune</city>
        <state>Maharashtra</state>
        <zip>411009</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sachin S Jamadar, D ORTHO</last_name>
      <phone>+918888788880</phone>
      <email>sac2751982@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Anant E Bagul, MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>September 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 9, 2013</study_first_submitted>
  <study_first_submitted_qc>April 12, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 16, 2013</study_first_posted>
  <last_update_submitted>September 16, 2014</last_update_submitted>
  <last_update_submitted_qc>September 16, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 17, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chaitanya Hospital, Pune</investigator_affiliation>
    <investigator_full_name>Dr. Sachin Jamadar</investigator_full_name>
    <investigator_title>CO-Investigator</investigator_title>
  </responsible_party>
  <keyword>Diabetes Mellitus stem cells [MNCS ]</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

